Cindy Colling

A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation

Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation

Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure

Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy

Pharmacology and Management of the Vitamin K Antagonists

Hospitalized Patients With Atrial Fibrillation and a High Risk of Stroke Are Not Being Provided With Adequate Anticoagulation

A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis

Antithrombotic therapy in atrial fibrillation: A review of randomized trials with special reference to the stroke prevention in atrial fibrillation II (SPAF II) trial

Guidelines for the diagnosis and treatment of chronic heart failure

Relationship Between Test Frequency and Outcomes of Anticoagulation: A Literature Review and Commentary with Implications for the Design of Randomized Trials of Patient Self-Management

Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations

Ximelagatran versus warfarin forstroke prevention in patientswith nonvalvular atrial fibrillation

Antithrombotic Therapy in Valvular Heart Disease

Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

Pulmonary Effect of Amiodarone in Patients With Heart Failure

Ventricular Arrhythmias in Adult Aortic Stenosis

Long-Term Anticoagulation Therapy for Atrial Fibrillation in Elderly Patients: Efficacy, Risk, and Current Patterns of Use

Optimizing therapy for complex or refractory heart failure: A management algorithm

Amiodarone versus Sotalol for Atrial Fibrillation

Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction

Wound repair and regeneration

Oral Anticoagulant Therapy

Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy

Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency

Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials

Percutaneous Repair or Surgery for Mitral Regurgitation

Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials

Choice of prosthetic heart valve for adult patients

Emergency Hospitalizations for Adverse Drug Events in Older Americans

Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events

Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates 11Reprints are not available.

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure

Management of atrial fibrillation in patients with heart failure

Prevention of thromboembolism in atrial fibrillation

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Thyroid Hormone and the Cardiovascular System

Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction

The MUSTT Study: Evaluating Testing and Treatment

Self-monitoring of oral anticoagulation: a systematic review and meta-analysis

Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease

Platelet Activation and Atherothrombosis

Managing Oral Anticoagulant Therapy

Management of Patients With Atrial Fibrillation

Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation∗∗The investigators and institutions participating in the study are listed in the Appendix.

Effect of Carvedilol on Survival in Severe Chronic Heart Failure

Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia

Population pharmacokinetic-pharmacodynamic analysis of fluindione in patients*

Evaluation of survival and ischaemic and thromboembolic event rates in patients with non-valvar atrial fibrillation in the general population when treated and untreated with warfarin

The Management of Chronic Heart Failure

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran

Consensus Guidelines for Coordinated Outpatient Oral Anticoagulation Therapy Management

Antithrombotic Therapy in Atrial Fibrillation

A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation

Task Force on Sudden Cardiac Death of the European Society of Cardiology

Evolving trends in the epidemiologic factors of heart failure: Rationale for preventive strategies and comprehensive disease management

Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin

Safety of Treatment with Oral Anticoagulants in the Elderly

The management of atrial fibrillation

Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty

Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemicdilated cardiomyopathy and asymptomaticnonsustained ventricular tachycardia—AMIOVIRT

Antithrombotic Therapy in Valvular Heart Disease—Native and Prosthetic

Prevalence and Incidence of Arrhythmias and Sudden Death in Heart Failure

Sudden Death Due to Cardiac Arrhythmias

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)

Improving the quality of anticoagulation of patients with atrial fibrillation in managed care organizations: results of the managing anticoagulation services trial

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation

The Pharmacology and Management of the Vitamin K Antagonists

Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction

An Analysis of the Lowest Effective Intensity of Prophylactic Anticoagulation for Patients with Nonrheumatic Atrial Fibrillation

Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment

Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction

Antithrombotic Therapy for Stroke Prevention in Atrial Fibrillation

Hemorrhagic Complications of Anticoagulant Treatment

Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart Failure

The inflammatory reflex

Systematic review of the management of atrial fibrillation in patients with heart failure

Antithrombotic Therapy in Atrial Fibrillation

Hemorrhagic Complications of Anticoagulant Treatment

Atrial Fibrillation

Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal

Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins

Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure

Increased Mortality after Dronedarone Therapy for Severe Heart Failure

Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization

Hemorrhagic Complications of Anticoagulant Treatment

The Impact of Patient Self-Testing of Prothrombin Time for Managing Anticoagulation: Rationale and Design of VA Cooperative Study #481—The Home INR Study (THINRS)

Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation

Antithrombotic Therapy in Atrial Fibrillation

Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure

Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin

Myocarditis

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

Effect of Amiodarone on Clinical Status and Left Ventricular Function in Patients With Congestive Heart Failure

[Guidelines for the management of patients with atrial fibrillation. Executive summary].

Warfarin Use among Ambulatory Patients with Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

Interaction of Dietary Factors with Oral Anticoagulants

Diagnosis and Management of the Metabolic Syndrome

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult

Amiodarone Inhibits Production of Tumor Necrosis Factor-α by Human Mononuclear Cells

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society

Chronic Heart Failure in the United States

A Multicomponent Intervention To Prevent Major Bleeding Complications in Older Patients Receiving Warfarin

A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias

Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy

Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation

Antithrombotic Therapy in Valvular Heart Disease

2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults

American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

Optimal Intensity of Warfarin Therapy for Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

Challenges of Establishing New Antithrombotic Therapies in Atrial Fibrillation

American Heart Association/American College of Cardiology Foundation guide to warfarin therapy11The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.This statement has been co-published in the April 1, 2003, issue of Circulation.This statement was approved by the American Heart Association Science Advisory and Coordinating Committee in October 2002 and by the American College of Cardiology Board of Trustees in February 2003. A single reprint is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596. Ask for reprint No. 71-0254. To purchase additional reprints: up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 410-528-4426, fax 410-528-4264, or e-mail klbradle@lww.com. To make photocopies for personal or educational use, call the Copyright Clearance Center, 978-750-8400.

Adverse Outcomes and Predictors of Underuse of Antithrombotic Therapy in Medicare Beneficiaries With Chronic Atrial Fibrillation

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

Spontaneous Conversion and Maintenance of Sinus Rhythm by Amiodarone in Patients With Heart Failure and Atrial Fibrillation

Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device

Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke

Resource Use and Survival of Patients Hospitalized with Congestive Heart Failure: Differences in Care by Specialty of the Attending Physician

Acute Coronary Findings at Autopsy in Heart Failure Patients With Sudden Death

Atrial fibrillation and anticoagulation: from randomised trials to practice

Use and Effectiveness of Warfarin in Medicare Beneficiaries With Atrial Fibrillation

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary

Multicenter Automatic Defibrillator Implantation Trial II (MADIT II): Design and Clinical Protocol

Optimal Oral Anticoagulant Therapy in Patients with Nonrheumatic Atrial Fibrillation and Recent Cerebral Ischemia

Atrial Fibrillation and Thromboembolism: A Decade of Progress in Stroke Prevention

Management of Deep Vein Thrombosis and Pulmonary Embolism

The Effects of Amiodarone on the Thyroid*

Hemorrhagic Complications of Anticoagulant Treatment

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Department of Veterans Affairs Cooperative Studies Program Clinical Trial Comparing Combined Warfarin and Aspirin With Aspirin Alone in Survivors of Acute Myocardial Infarction

Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation

Amiodarone in Patients with Congestive Heart Failure and Asymptomatic Ventricular Arrhythmia

Congestive heart failure: Survival trial of antiarrhythmic therapy (CHF STAT)

Combination Hemotherapy and Mortality Prevention (CHAMP) Study Rationale and Design